Biomarkers in atopic dermatitis
Journal of Allergy and Clinical Immunology · 2023-05 · 151 (5) · 1163-1168
DOI: 10.1016/j.jaci.2023.01.019 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Allergy and Clinical Immunology, 2023-05. Verfasst von Daphne Bakker und 4 weiteren Autor:innen. Beteiligte Einrichtung: National Expertise Center for Atopic Dermatitis, Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, the Netherlan…. Hauptthemen laut MEDLINE: Dermatitis, Atopic. Die Arbeit wurde bisher 113-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Atopic dermatitis (AD) is a complex and highly heterogeneous inflammatory skin disease. Given the highly heterogeneous character of AD, it is unlikely that every patient will respond equally to a particular treatment. The recent introduction of novel targeted therapies for AD has driven the need for patient stratification based on immunologic biomarkers. We have reviewed the use of different types of biomarkers as potential tools in the movement toward personalized medicine in AD, comprising different ways of endotyping patients with AD based on immunologic profiles and predictive biomarkers. The application of biomarkers will result in better characterization and stratification of patients and allow better comparison of current and new treatments. The ultimate goal will be to switch from the current generalized "one-drug-fits-all" management to more personalized "patient endotype-specific" management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Expertise Center for Atopic Dermatitis, Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, the Netherlands. Electronic address: d.s.bakker-4@umcutrecht.nl.
- National Expertise Center for Atopic Dermatitis, Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, the Netherlands.
- Center for Translational Immunology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, the Netherlands.
Zitieren
APA
Bakker, D., de Bruin-Weller, M., Drylewicz, J., van Wijk, F., & Thijs, J. (2023). Biomarkers in atopic dermatitis. Journal of Allergy and Clinical Immunology, 151(5), 1163-1168. https://doi.org/10.1016/j.jaci.2023.01.019
Vancouver
Bakker D, de Bruin-Weller M, Drylewicz J, van Wijk F, Thijs J. Biomarkers in atopic dermatitis. Journal of Allergy and Clinical Immunology. 2023;151(5):1163-1168. doi:10.1016/j.jaci.2023.01.019
BibTeX
@article{Bakker2023,
author = {Bakker, Daphne and de Bruin-Weller, Marjolein and Drylewicz, Julia and van Wijk, Femke and Thijs, Judith},
title = {Biomarkers in atopic dermatitis},
journal = {Journal of Allergy and Clinical Immunology},
year = {2023},
volume = {151},
number = {5},
pages = {1163--1168},
doi = {10.1016/j.jaci.2023.01.019}
}
EUVIMED